DIAN TU - Safety MRI Scan


About this study

This is a subaward with Washington University in St. Louis (Wash U) as the prime site. This study is designed to assess the efficacy of drug treatment to pre-AD subject. Dr. Jack's ADIR lab will have no patient contact and will only receive de-identified data from Wash U. ADIR will assess the images for MRI protocol compliance and quality. Neuroradiologists in the lab will provide safety assessments and provide inclusion/exclusion recommendations. Mayo Clinic in Rochester will also be a safety MRI site for local participants who are enrolled at other performance sites. Research participants are required to have MR safety scans to ensure safety for continued participation at their respective enrollment site. These safety scans can be done at a clinic/hospital close to their home for patient convenience.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Subjects must be enrolled in DIAN Study at another site. Only safety MRI Scans are being performed at Mayo.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Clifford Jack, M.D.

Closed-enrolling by invitation

What is this? (?)
Not open to everyone who meets the eligibility criteria, but only those invited to participate by the study team.

Contact information:

Paul Lewis

(507) 284-1171


More information


Publications are currently not available

Mayo Clinic Footer